Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Medtronic plcMDT · Entity 2888 | EVP & President of Americas | July 29, 2022 | August 02, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Medtronic plc
Report date July 29, 2022 · Filed August 02, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 37,374 |
Reported balance
After 2022-07-29 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2022-07-29 · Disposition to issuer · Disposed 6,543 · Balance 37,374 F1: Represents shares of performance-vesting restricted stock granted in July 2019 and earned dividend equivalent units that have been forfeited based on the Company's failure to meet the cumulative three year non-GAAP diluted earnings per share ("EPS") growth performance target. F2: This balance increased by 795 shares due to exempt acquisitions through dividend reinvestment and our employee stock purchase plan. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares of performance-vesting restricted stock granted in July 2019 and earned dividend equivalent units that have been forfeited based on the Company's failure to meet the cumulative three year non-GAAP diluted earnings per share ("EPS") growth performance target.
F2: This balance increased by 795 shares due to exempt acquisitions through dividend reinvestment and our employee stock purchase plan.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 29, 2022 Filed Aug 2, 2022 17:44 UTC | Medtronic plc MDT · Entity 2888 | Disposition to issuerOrdinary Shares | 6,543 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-020222 · form4.xml · nonDerivative · entry 1 Liddicoat John R · CIK 0001752060 · EVP & President of Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,374 F1 · shares: Represents shares of performance-vesting restricted stock granted in July 2019 and earned dividend equivalent units that have been forfeited based on the Company's failure to meet the cumulative three year non-GAAP diluted earnings per share ("EPS") growth performance target. F2 · balance_after: This balance increased by 795 shares due to exempt acquisitions through dividend reinvestment and our employee stock purchase plan. Read SEC document |
| November 05, 2021 Filed Nov 9, 2021 18:03 UTC | Medtronic plc MDT · Entity 2888 | Tax withholdingOrdinary Shares | 139 | $122.98 | $17,094.22 |
DisclosureSEC source: 0001127602-21-028741 · form4.xml · nonDerivative · entry 1 Liddicoat John R · CIK 0001752060 · EVP & President of Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,998 F1 · balance_after: The reported transaction involved the withholding of 139 shares of stock issuable upon the early vesting of an equal number of restricted stock units to pay taxes associated with the reporting person becoming retirement eligible. F2 · balance_after: This balance increased by 290 shares due to exempt transactions such as dividend reinvestment and employee stock purchase plan. Read SEC document |
| August 02, 2021 Filed Aug 4, 2021 18:19 UTC | Medtronic plc MDT · Entity 2888 | GrantPerformance Share Units · Derivative | 8,381 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-023102 · form4.xml · derivative · entry 5 Liddicoat John R · CIK 0001752060 · EVP & President of Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,381 Underlying: Performance Share Units · 8,381 shares Expires not disclosed F5 · derivative.exercise_price: Each performance share unit represents a contingent right to receive one share of Medtronic common stock. F6 · shares: The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 8,381 shares will be issued. The actual number of shares to be issued could range from a low of 1,677 at minimum performance to a high of 16,762 shares at maximum performance. If minimum performance metrics are not met, such PSUs may vest at 0 shares. F7 · derivative.exercise_date: Vests on August 2, 2024. F7 · derivative.expiration_date: Vests on August 2, 2024. Read SEC document |
| August 02, 2021 Filed Aug 4, 2021 18:19 UTC | Medtronic plc MDT · Entity 2888 | GrantStock Option (Right to Buy) · Derivative | 1,085 | $0.00 Strike: $131.26 | $0.00 |
DisclosureSEC source: 0001127602-21-023102 · form4.xml · derivative · entry 4 Liddicoat John R · CIK 0001752060 · EVP & President of Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,085 Underlying: Ordinary Shares · 1,085 shares Expires 2031-08-02 F4 · derivative.exercise_date: These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. Read SEC document |
| August 02, 2021 Filed Aug 4, 2021 18:19 UTC | Medtronic plc MDT · Entity 2888 | GrantStock Option (Right to Buy) · Derivative | 28,641 | $0.00 Strike: $131.26 | $0.00 |
DisclosureSEC source: 0001127602-21-023102 · form4.xml · derivative · entry 3 Liddicoat John R · CIK 0001752060 · EVP & President of Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,641 Underlying: Ordinary Shares · 28,641 shares Expires 2031-08-02 F4 · derivative.exercise_date: These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. Read SEC document |
| August 02, 2021 Filed Aug 4, 2021 18:19 UTC | Medtronic plc MDT · Entity 2888 | GrantOrdinary Shares | 3,353 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-023102 · form4.xml · nonDerivative · entry 2 Liddicoat John R · CIK 0001752060 · EVP & President of Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,847 F3 · kind: The restrictions on the award shall lapse 100% on the third anniversary of the Grant Date. Read SEC document |
| August 02, 2021 Filed Aug 4, 2021 18:19 UTC | Medtronic plc MDT · Entity 2888 | Tax withholdingOrdinary Shares | 3,258 | $131.31 | $427,807.98 |
DisclosureSEC source: 0001127602-21-023102 · form4.xml · nonDerivative · entry 1 Liddicoat John R · CIK 0001752060 · EVP & President of Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,494 F1 · balance_after: This amount has been adjusted to correct a mathematical error in exempt transactions such as dividend reinvestment. F2 · balance_after: This balance increased by 284 shares due to exempt transactions such as dividend reinvestment and employee stock purchase plan. Read SEC document |
| May 28, 2021 Filed Jun 1, 2021 17:55 UTC | Medtronic plc MDT · Entity 2888 | Exercise / conversionStock Option (Right to Buy) · Derivative | 15,142 | $0.00 Strike: $88.06 | $0.00 |
DisclosureSEC source: 0001127602-21-018560 · form4.xml · derivative · entry 9 Liddicoat John R · CIK 0001752060 · EVP & President of Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 15,142 shares Expires 2026-08-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F3 · derivative.exercise_date: These options become exercisable at the rate of 25% of the shares granted per year beginning one year from grant date. Read SEC document |
| May 28, 2021 Filed Jun 1, 2021 17:55 UTC | Medtronic plc MDT · Entity 2888 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,136 | $0.00 Strike: $88.06 | $0.00 |
DisclosureSEC source: 0001127602-21-018560 · form4.xml · derivative · entry 8 Liddicoat John R · CIK 0001752060 · EVP & President of Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 1,136 shares Expires 2026-08-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F3 · derivative.exercise_date: These options become exercisable at the rate of 25% of the shares granted per year beginning one year from grant date. Read SEC document |
| May 28, 2021 Filed Jun 1, 2021 17:55 UTC | Medtronic plc MDT · Entity 2888 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,283 | $0.00 Strike: $78.00 | $0.00 |
DisclosureSEC source: 0001127602-21-018560 · form4.xml · derivative · entry 7 Liddicoat John R · CIK 0001752060 · EVP & President of Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 1,283 shares Expires 2025-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F3 · derivative.exercise_date: These options become exercisable at the rate of 25% of the shares granted per year beginning one year from grant date. Read SEC document |
| May 28, 2021 Filed Jun 1, 2021 17:55 UTC | Medtronic plc MDT · Entity 2888 | Exercise / conversionStock Option (Right to Buy) · Derivative | 17,095 | $0.00 Strike: $78.00 | $0.00 |
DisclosureSEC source: 0001127602-21-018560 · form4.xml · derivative · entry 6 Liddicoat John R · CIK 0001752060 · EVP & President of Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 17,095 shares Expires 2025-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F3 · derivative.exercise_date: These options become exercisable at the rate of 25% of the shares granted per year beginning one year from grant date. Read SEC document |
| May 28, 2021 Filed Jun 1, 2021 17:55 UTC | Medtronic plc MDT · Entity 2888 | SaleOrdinary Shares | 34,656 | $126.65 | $4,389,182.40 |
DisclosureSEC source: 0001127602-21-018560 · form4.xml · nonDerivative · entry 5 Liddicoat John R · CIK 0001752060 · EVP & President of Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,551 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| May 28, 2021 Filed Jun 1, 2021 17:55 UTC | Medtronic plc MDT · Entity 2888 | Exercise / conversionOrdinary Shares | 15,142 | $88.06 | $1,333,404.52 |
DisclosureSEC source: 0001127602-21-018560 · form4.xml · nonDerivative · entry 4 Liddicoat John R · CIK 0001752060 · EVP & President of Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,207 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| May 28, 2021 Filed Jun 1, 2021 17:55 UTC | Medtronic plc MDT · Entity 2888 | Exercise / conversionOrdinary Shares | 1,136 | $88.06 | $100,036.16 |
DisclosureSEC source: 0001127602-21-018560 · form4.xml · nonDerivative · entry 3 Liddicoat John R · CIK 0001752060 · EVP & President of Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,065 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| May 28, 2021 Filed Jun 1, 2021 17:55 UTC | Medtronic plc MDT · Entity 2888 | Exercise / conversionOrdinary Shares | 1,283 | $78.00 | $100,074.00 |
DisclosureSEC source: 0001127602-21-018560 · form4.xml · nonDerivative · entry 2 Liddicoat John R · CIK 0001752060 · EVP & President of Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,929 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| May 28, 2021 Filed Jun 1, 2021 17:55 UTC | Medtronic plc MDT · Entity 2888 | Exercise / conversionOrdinary Shares | 17,095 | $78.00 | $1,333,410.00 |
DisclosureSEC source: 0001127602-21-018560 · form4.xml · nonDerivative · entry 1 Liddicoat John R · CIK 0001752060 · EVP & President of Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,646 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F2 · balance_after: This balance increased by 562 shares due to exempt transactions such as dividend reinvestment and employee stock purchase plan. Read SEC document |
| November 03, 2020 Filed Nov 5, 2020 18:06 UTC | Medtronic plc MDT · Entity 2888 | Tax withholdingOrdinary Shares | 128 | $103.13 | $13,200.64 |
DisclosureSEC source: 0001127602-20-028281 · form4.xml · nonDerivative · entry 1 Liddicoat John R · CIK 0001752060 · EVP & President of Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,989 F1 · balance_after: This balance increased by 290 shares due to exempt transactions such as dividend reinvestment and employee stock purchase plan. Read SEC document |
| October 09, 2020 Filed Oct 14, 2020 18:53 UTC | Medtronic plc MDT · Entity 2888 | GrantPerformance Share Units · Derivative | 8,742 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-026956 · form4.xml · derivative · entry 1 Liddicoat John R · CIK 0001752060 · EVP & President of Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,742 Underlying: Performance Share Units · 8,742 shares Expires not disclosed F1 · derivative.exercise_price: Each performance share unit represents a contingent right to receive one share of Medtronic common stock. F2 · shares: The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 8,742 shares will be issued. The actual number of shares to be issued could range from a low of 1,749 at minimum performance to a high of 17,484 shares at maximum performance. If minimum performance metrics are not met, such PSUs may vest at 0 shares. F3 · derivative.exercise_date: Vests on August 3, 2023. F3 · derivative.expiration_date: Vests on August 3, 2023. Read SEC document |
| August 03, 2020 Filed Aug 5, 2020 17:01 UTC | Medtronic plc MDT · Entity 2888 | GrantStock Option (Right to Buy) · Derivative | 39,672 | $0.00 Strike: $97.33 | $0.00 |
DisclosureSEC source: 0001127602-20-022906 · form4.xml · derivative · entry 4 Liddicoat John R · CIK 0001752060 · EVP & President of Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,672 Underlying: Ordinary Shares · 39,672 shares Expires 2030-08-03 F2 · derivative.exercise_date: These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. Read SEC document |
| August 03, 2020 Filed Aug 5, 2020 17:01 UTC | Medtronic plc MDT · Entity 2888 | GrantStock Option (Right to Buy) · Derivative | 1,575 | $0.00 Strike: $97.33 | $0.00 |
DisclosureSEC source: 0001127602-20-022906 · form4.xml · derivative · entry 3 Liddicoat John R · CIK 0001752060 · EVP & President of Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,575 Underlying: Ordinary Shares · 1,575 shares Expires 2030-08-03 F2 · derivative.exercise_date: These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. Read SEC document |
| August 03, 2020 Filed Aug 5, 2020 17:01 UTC | Medtronic plc MDT · Entity 2888 | GrantStock Option (Right to Buy) · Derivative | 35,894 | $0.00 Strike: $97.33 | $0.00 |
DisclosureSEC source: 0001127602-20-022906 · form4.xml · derivative · entry 2 Liddicoat John R · CIK 0001752060 · EVP & President of Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,894 Underlying: Ordinary Shares · 35,894 shares Expires 2030-08-03 F2 · derivative.exercise_date: These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. Read SEC document |
| August 03, 2020 Filed Aug 5, 2020 17:01 UTC | Medtronic plc MDT · Entity 2888 | GrantOrdinary Shares | 3,905 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-022906 · form4.xml · nonDerivative · entry 1 Liddicoat John R · CIK 0001752060 · EVP & President of Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,827 F1 · kind: The restrictions on these restricted stock units shall lapse 100% on the third anniversary of the Grant Date. Read SEC document |
| July 31, 2020 Filed Aug 3, 2020 17:48 UTC | Medtronic plc MDT · Entity 2888 | Tax withholdingOrdinary Shares | 2,269 | $96.48 | $218,913.12 |
DisclosureSEC source: 0001127602-20-022598 · form4.xml · nonDerivative · entry 1 Liddicoat John R · CIK 0001752060 · EVP & President of Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,922 F1 · balance_after: This balance increased by 1,080 shares due to exempt transactions such as dividend reinvestment and employee stock purchase plan. Read SEC document |
| August 01, 2019 Filed Aug 2, 2019 18:34 UTC | Medtronic plc MDT · Entity 2888 | Tax withholdingOrdinary Shares | 8,298 | $102.37 | $849,466.26 |
DisclosureSEC source: 0001127602-19-025935 · form4.xml · nonDerivative · entry 2 Liddicoat John R · CIK 0001752060 · EVP & President of Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,111 Read SEC document |
| August 01, 2019 Filed Aug 2, 2019 18:34 UTC | Medtronic plc MDT · Entity 2888 | Tax withholdingOrdinary Shares | 1,644 | $102.37 | $168,296.28 |
DisclosureSEC source: 0001127602-19-025935 · form4.xml · nonDerivative · entry 1 Liddicoat John R · CIK 0001752060 · EVP & President of Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,409 Read SEC document |
| July 29, 2019 Filed Jul 31, 2019 18:01 UTC | Medtronic plc MDT · Entity 2888 | GrantStock Option (Right to Buy) · Derivative | 1,615 | $0.00 Strike: $103.26 | $0.00 |
DisclosureSEC source: 0001127602-19-025557 · form4.xml · derivative · entry 3 Liddicoat John R · CIK 0001752060 · EVP & President of Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,615 Underlying: Ordinary Shares · 1,615 shares Expires 2029-07-29 F3 · derivative.exercise_date: These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. Read SEC document |
| July 29, 2019 Filed Jul 31, 2019 18:01 UTC | Medtronic plc MDT · Entity 2888 | GrantStock Option (Right to Buy) · Derivative | 40,910 | $0.00 Strike: $103.26 | $0.00 |
DisclosureSEC source: 0001127602-19-025557 · form4.xml · derivative · entry 2 Liddicoat John R · CIK 0001752060 · EVP & President of Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,910 Underlying: Ordinary Shares · 40,910 shares Expires 2029-07-29 F3 · derivative.exercise_date: These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. Read SEC document |
| July 29, 2019 Filed Jul 31, 2019 18:01 UTC | Medtronic plc MDT · Entity 2888 | GrantOrdinary Shares | 6,134 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-025557 · form4.xml · nonDerivative · entry 1 Liddicoat John R · CIK 0001752060 · EVP & President of Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,053 F1 · kind: The restrictions on these restricted stock units shall lapse 100% on the third anniversary of the Grant Date if the Company's cumulative non-GAAP diluted earnings per share ("EPS") growth during the 36-month period ending on the last day of the Company's fiscal year 2022 equals or exceeds a 3% cumulative compound annual growth rate, as determined by the Compensation Committee. F2 · balance_after: This balance increased by 876 shares due to exempt transactions such as dividend reinvestment and employee stock purchase plan. Read SEC document |
| October 29, 2018 Filed Oct 31, 2018 16:37 UTC | Medtronic plc MDT · Entity 2888 | GrantStock Option (Right to Buy) · Derivative | 17,157 | $0.00 Strike: $89.45 | $0.00 |
DisclosureSEC source: 0001127602-18-031436 · form4.xml · derivative · entry 2 Liddicoat John R · CIK 0001752060 · EVP & President of Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,157 Underlying: Ordinary Shares · 17,157 shares Expires 2028-10-29 F3 · derivative.exercise_date: These options become exercisable at the rate of 25% of the shares granted per year beginning from July 30, 2018. Read SEC document |
| October 29, 2018 Filed Oct 31, 2018 16:37 UTC | Medtronic plc MDT · Entity 2888 | GrantOrdinary Shares | 2,982 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-031436 · form4.xml · nonDerivative · entry 1 Liddicoat John R · CIK 0001752060 · EVP & President of Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,043 F1 · kind: The restrictions on these restricted stock units shall lapse 100% on the third anniversary of the Grant Date if the Company's cumulative non-GAAP diluted earnings per share ("EPS") growth during the 36-month period ending on the last day of the Company's fiscal year 2021 equals or exceeds a 3% cumulative compound annual growth rate, as determined by the Compensation Committee. F2 · balance_after: This balance increased by 293 shares due to exempt transactions such as dividend reinvestment. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.